Victor P. Ghidu, Ph.D.

Associate

Victor P. Ghidu, Ph.D. serves intellectual property (IP) clients in patent matters, including drafting and prosecuting patent applications, freedom to operate analysis, and due diligence for transactions with an IP element. Victor's practice spans an array of technologies pertaining to the chemical and biotechnology arts, including small molecule drugs, natural product conjugates, biologics, polymers, and medicinal formulations, while at the same time regularly crossing into fields such as organic light emitting diodes, fiber optics, and medical devices. He is fluent in Romanian.

Extended Profile

Before joining Morgan Lewis, Victor practiced patent law at a boutique IP firm in the greater Philadelphia area. He brings to his practice a wealth of experience as a research scientist in organic and medicinal chemistry.

Victor has co-authored several publications (selected: Ghidu et al., “A new and efficient synthetic route for the anxiolytic agent CL285032” Bioorg. Med. Chem. Lett., 2011, 21(1), 259-261; Ghidu et al., “Combined Chemical and Biosynthetic Route to Access a New Apoptolidin Congener” Org. Lett., 2009, 11 (14), 3032-3034; Ghidu et al., “Synthesis and Evaluation of the Cytotoxicity of Apoptolidinones A and D” J. Org. Chem., 2008, 73 (13), 4949-4955; Pearson and Ghidu, “A New Paradigm for Cationic Cyclization of Iron Tricarbonyl Diene Complexes with Pendant Alkenes and Arenes” Org. Lett., 2002, 4 (23), 4069-4071), and is credited as a co-inventor on two patent applications (WO 2014/150395, and WO 2015/054117).

Education

Temple University, Beasley School of Law, 2014, J.D.
Case Western Reserve University, 2004, Ph.D.
University of Bucharest, Romania, 1994, B.A.
University of Bucharest, Romania, 1995, M.S.

Admissions

Pennsylvania
New Jersey
US Patent and Trademark Office

Clerkships

Intern to Judge Gene E.K. Pratter of the US District Court for the Eastern District of Pennsylvania (2013 - 2014)

Awards and Affiliations

Member, American Chemical Society

Publications

2/28/2017 - Highest Patent Court Narrows Scope of Covered Business Review

2011 - Co-author, A New and Efficient Synthetic Route for the Anxiolytic Agent CL285032, Bioorganic & Medicinal Chemistry Letters, Volume 21, Issue 1